$48.46
Price
$2.8B
Market Cap
—
P/E Ratio
11.2
Forward P/E
$-0.51
EPS (TTM)
—
Dividend Yield
$384M
Cash
$41M
Total Debt
58M
Shares Out
$32.20
$59.68
52-Week Range
Institutional Ownership of SUPERNUS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Third Avenue Management|Matthew Fine
|
152.7K | $8M | $31.09 | +57.93% |
Trading Activity for SUPERNUS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -19.4% | 152.7K | $8M | $50.36 | |
| 2024-Q3 | |||||
| BUY | +0.2% | 189.5K | $6M | $31.08 | |
| 2024-Q2 | |||||
| BUY | +18.4% | 189.1K | $5M | $28.97 | |
| 2023-Q4 | |||||
| BUY | +37.0% | 159.7K | $5M | $27.09 | |
| 2023-Q3 | |||||
| BUY | +73.8% | 116.5K | $3M | $30.50 | |
| 2023-Q2 | |||||
| BUY | NEW | 67.1K | $2M | $35.29 | |
| 2022-Q2 | |||||
| BUY | NEW | 2.5K | $72000 | $28.22 | |
Insider Trading for SUPERNUS PHARMACEUTICALS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.